VR Logo

Laurus Labs Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 2005

Chairman: Malempati Venugopala Rao

Managing Director: --

Group: --

Listing: NSE: LAURUSLABS, BSE: 540222

Headquarters: Vishakhapatnam, Andhra Pradesh

Website: www.lauruslabs.com

Key Facts

Market cap: R 5,670.75 Cr

Revenue (TTM): R 2,831.72 Cr

Earnings (TTM): R 255.27 Cr

Cash: R 1.74 Cr

Total Debt: R 1,056.88 Cr

Promoters' ownership: 32.04%

Liquidity: High

52 Week range: R 295.00 - 587.80

Face value: R10.00

Shares outstanding: 10,69,14,499

9 Years Aggregate:

  • CFO: 1,685.08 Cr
  • EBITDA: 2,716.60 Cr
  • Net Profit: 1,117.25 Cr

Stock Performance

Time Period Laurus Labs S&P BSE Healthcare S&P BSE Small Cap
YTD47.3421.71-8.00
1 month12.613.208.92
3 months54.9231.8633.95
1 Year50.9726.34-11.99
3 Years-5.514.73-6.80
5 Years---0.392.20
10 Years--11.083.30
As on 03-Jul-2020
Year Laurus Labs S&P BSE Small Cap S&P BSE Healthcare
2019-6.06-6.85-3.55
2018-29.95-23.41-5.89
201712.9059.640.49

Review & Analysis